LONDON, ONTARIO -- (MARKET WIRE) -- November 02, 2006 -- Stellar Pharmaceuticals Inc., (TSX VENTURE: SLX)(OTCBB: SLXCF)(“Stellar”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that it plans to release its 2006 third quarter financial results for the period ended September 30, 2006 prior to the opening of the stock market on Thursday, November 9, 2006. Management will conduct a conference call that morning at 11:00 a.m. Eastern Time to discuss these results. Interested parties may participate in the call by dialing 877-461-2814 (in the United States) or 416-695-9753 (in Canada) approximately 10 minutes before the call is scheduled to begin and ask to be connected to the Stellar Pharmaceuticals Conference Call.
